ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Cutaneous sarcoidosis | 23.03.15.004; 10.02.06.002 | 0.000650% | | Not Available |
Cyst | 16.02.02.002; 08.03.05.001 | 0.001732% | | Not Available |
Cystitis | 20.03.02.002; 11.01.14.001 | 0.000650% | | |
Death | 08.04.01.001 | 0.017456% | | |
Decreased activity | 19.11.01.002; 08.01.01.006 | 0.007796% | | Not Available |
Dehydration | 14.05.05.001 | 0.007363% | | |
Depressed level of consciousness | 17.02.04.002 | - | - | |
Depression | 19.15.01.001 | - | - | |
Dermal cyst | 23.10.02.001; 16.26.02.001 | 0.001732% | | Not Available |
Dermatitis | 23.03.04.002 | 0.004114% | | Not Available |
Dermatitis acneiform | 23.02.01.004 | 0.005197% | | |
Dermatitis allergic | 23.03.04.003; 10.01.03.014 | 0.000650% | | Not Available |
Dermatitis bullous | 23.03.01.002 | 0.001732% | | |
Dermatitis exfoliative | 23.03.07.001; 10.01.01.004 | 0.003248% | | |
Dermatitis infected | 23.03.04.024; 11.01.12.011 | 0.000433% | | Not Available |
Diabetes mellitus inadequate control | 14.06.01.004; 05.06.01.004 | 0.000433% | | Not Available |
Diarrhoea | 07.02.01.001 | - | - | |
Diplopia | 17.17.01.005; 06.02.06.002 | - | - | Not Available |
Disorientation | 17.02.05.015; 19.13.01.002 | - | - | Not Available |
Disseminated intravascular coagulation | 24.01.01.010; 01.01.02.002 | 0.000226% | | |
Dizziness | 24.06.02.007; 17.02.05.003; 02.01.02.004 | - | - | |
Drug eruption | 23.03.05.001; 10.01.01.005; 08.01.06.015 | 0.003032% | | Not Available |
Drug hypersensitivity | 10.01.01.001 | - | - | Not Available |
Dry mouth | 07.06.01.002 | - | - | |
Dry skin | 23.03.03.001 | 0.006713% | | |
Duodenal ulcer | 07.04.02.002 | 0.000433% | | |
Dupuytren's contracture | 15.03.03.003 | 0.001299% | | Not Available |
Dysaesthesia | 17.02.06.003 | 0.000433% | | |
Dysarthria | 19.19.03.001; 17.02.08.001 | - | - | |
Dysgeusia | 17.02.07.003; 07.14.03.001 | 0.007796% | | |